Login

Financial Snapshot

Revenue
TTM
$257.6K
Gross Margin
TTM
82.18%
Net Income
TTM
-$2.658M
Current Assets
2025 Q4
$1.111M
Current Liabilities
2025 Q4
$9.068M
Current Ratio
2025 Q4
12.25%
Total Assets
2025 Q4
$14.24M
Total Liabilities
2025 Q4
$9.219M
Book Value
2025 Q4
5.017M
Cash
2025 Q4
$5.000K
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$3.026M

Stock Price

Loading...
Market Cap: $45.57 Million

About Optimi Health Corp

Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. With its vertically integrated approach, the Company owns and operates two purpose built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada. Additionally, it holds a Dealer’s Licence under Canada’s Narcotic Control Regulations, allowing the Company to possess, produce, assemble, sell and deliver psilocybin and other psychedelic substances within the regulated framework set forth by Health Canada.

Industry: Pharmaceutical Preparations

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support